Efficacy and Safety of Lerodalcibep in Patients With or at High Risk of Cardiovascular Disease

Overview of attention for article published in JAMA Cardiology, September 2024

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (98th percentile)
High Attention Score compared to outputs of the same age and source (93rd percentile)

Mentioned by

news: 10 news outlets
blogs: 1 blog
twitter: 48 X users

facebook: 2 Facebook pages
guideline: 1 clinical guideline source

Readers on

mendeley: 34 Mendeley

So far, Altmetric has seen 59 X posts from 48 X users, with an upper bound of 714,761 followers.

RT @ikunkkimoo: Efficacy and Safety of Lerodalcibep in Patients With or at High Risk of Cardiovascular Disease — A Randomized Clinical Tria…

RT @Gurleen_Kaur96: 2/ Background: In LIBerate-HR trial, pts w/ established or at high risk for CVD and on stable statin therapy were rand…

2/ Background: In LIBerate-HR trial, pts w/ established or at high risk for CVD and on stable statin therapy were randomized to lerodalcibep vs. placebo Significant reduction in LDL-C: -56.3% in lerodalcibep group vs. -0.14% in the placebo group http…

RT @JAMACardio: Lerodalcibep dosed monthly and stable at ambient temperatures significantly reduced LDL-C in patients with CVD or at high r…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 55 additional X posts.